- /
- Supported exchanges
- / US
- / SCNI.NASDAQ
Scinai Immunotherapeutics Ltd (SCNI NASDAQ) stock market data APIs
Scinai Immunotherapeutics Ltd Financial Data Overview
Scinai Immunotherapeutics Ltd., a biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious and autoimmune diseases in Israel. It develops nanosized VHH antibodies (nanoAbs) targeting diseases with unmet medical needs; and PC111, a monoclonal antibody for treating pemphigus, steven johnson's syndrome, and toxic epidermal necrolysis. The company also provides contract development and manufacturing organization services to biotech companies. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Gottingen for the development and commercialization of COVID-19 nanosized antibody. The company has a strategic collaboration with Recipharm Israel Ltd for the development of Lifecycle CDMO Platform. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Scinai Immunotherapeutics Ltd data using free add-ons & libraries
Get Scinai Immunotherapeutics Ltd Fundamental Data
Scinai Immunotherapeutics Ltd Fundamental data includes:
- Net Revenue: 1 311 K
- EBITDA: -6 121 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Scinai Immunotherapeutics Ltd Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2025-11-28
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Scinai Immunotherapeutics Ltd News
New
Scinai Immunotherapeutics reports FY results
* Scinai Immunotherapeutics press release [https://seekingalpha.com/pr/20458831-scinai-reports-full-year-2025-results-with-cdmo-revenues-doubling-and-strategic-expansion] (SCNI [https://seekingalpha...
Scinai Immunotherapeutics Receives Nasdaq Notification Regarding Minimum Bid Price
JERUSALEM, March 16, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai" or the "Company"), today announced that it received a written notification from the Nasdaq Listing Qua...
Here are the top movers in Wednesday's session.
Curious about what's happening in today's session? Check out the latest stock movements and price changes. [topmovers] TOP GAINERS TICKER CHANGE COMMENT MNTS [https://www.chartmill.com/s...
There are notable gap-ups and gap-downs in today's session.
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session. [gap] TODAY'S GAP UP STOCKS TICKER CHANGE COMMENT ...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.